← Leaderboards
Tara Murty
Stanford University
$155,397
Attributed
$155,397
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $41.8K · FY2022–25$50K$37.5K$25K$12.5K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$155,397 · 1
By mechanism
F30$155,397 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Robert M. Sapolsky$8,477,671
- Robert Lowsky$7,343,385
- Steven E Artandi$26,596,623
- Helen M Blau$36,149,136
- John Martin Brown$14,329,263
Others in their field
Other Rising Stars on “Adoptive Cell Transfers”
- Javier Caravaca · University Of California, San Francisco$3,728,080
- Magnus Adrian Gero Hoffmann · California Institute Of Technology$3,559,750
- Torben Schiffner · Vanderbilt University$3,383,634
- Amy M Moskop · Medical College Of Wisconsin$3,357,500
- Bozena Korczak · Vascular Vision Pharmaceuticals Company$3,058,782
- Nathan Schuldt · University Of Minnesota$2,999,774
Research focus
Adoptive Cell TransfersDedicationsAntigen TargetingBlood Component RemovalBeta-GalactosidaseCancer TherapyCareerBiologyCatalytic DomainCell AgingB Lymphoid MalignancyCellsCell TherapyCellular BiologyCessation Of LifeCharacteristicsChemistryCar T Cell TherapyChimeric Antigen Receptor T CellsChronologyClinical PredictorsComputer AnalysisCell PhysiologyDisorder Control
Grant awards (4)
Defining the Role of Senescence in Limiting Therapeutic Efficacy of CAR T Cells$33,538
F30 · FY2025 · CA · contact PI
Defining the Role of Senescence in Limiting Therapeutic Efficacy of CAR T Cells$41,787
F30 · FY2024 · CA · contact PI
Defining the Role of Senescence in Limiting Therapeutic Efficacy of CAR T Cells$40,507
F30 · FY2023 · CA · contact PI
Defining the Role of Senescence in Limiting Therapeutic Efficacy of CAR T Cells$39,565
F30 · FY2022 · CA · contact PI